• Mashup Score: 3

    Mechanistic research suggests using Cannabis sativa L. (cannabis or marijuana) may increase the risk of cardiometabolic disease, but observational studies investigating associations between cannabis use and myocardial infarction (MI) have reported inconsistent results. Cross-sectional National Health and Nutrition Examination Survey data from five 2-year cycles between 2009 and 2018 and representing 9,769 middle-aged adults (35 to 59 years old) were analyzed. Multivariable logistic regression models accounting for sampling weights and adjusting for cardiovascular risk factors were used to assess associations between a history of monthly cannabis use before MI and a subsequent MI.

    Tweet Tweets with this article
    • Authors report from #NHANES that #Cannabis use isn't associated with #ACS : open for discussion... https://t.co/b5gsHeOc1g

  • Mashup Score: 292

    ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation. They should be essential in everyday clinical decision making.

    Tweet Tweets with this article
    • RT @escardio: NEW: 2023 #ESCGuidelines for the management of #AcuteCoronarySyndromes 👉https://t.co/QsxXO7blnP #ACS #medtwitter #ESCCongre…

  • Mashup Score: 20

    ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation. They should be essential in everyday clinical decision making.

    Tweet Tweets with this article
    • NEW: 2023 #ESCGuidelines for the management of #AcuteCoronarySyndromes 👉https://t.co/QsxXO7blnP #ACS #medtwitter #ESCCongress https://t.co/pk1lH8f7cy

  • Mashup Score: 9

    Review in-depth clinical information, latest medical news, and guidelines about acute coronary syndrome, classified as either ST segment elevation myocardial infarction (STEMI myocardial infarction) or non-STEMI myocardial infarction (NSTE or non-ST myocardial infarction) as reflected on ECG. Read about the latest angina and STEMI treatment.

    Tweet Tweets with this article
    • 🚨 Did you know that the 2023 ESC Guidelines for the Management of Acute Coronary Syndromes will be released August 28th?!? ➡️ Get up to speed with our ACS activities ahead of #ESC2023 here: https://t.co/tNxMpX2Zyx #ACS #CardioX #ESCCongress https://t.co/YHQaOM28MR

  • Mashup Score: 11

    Review in-depth clinical information, latest medical news, and guidelines about acute coronary syndrome, classified as either ST segment elevation myocardial infarction (STEMI myocardial infarction) or non-STEMI myocardial infarction (NSTE or non-ST myocardial infarction) as reflected on ECG. Read about the latest angina and STEMI treatment.

    Tweet Tweets with this article
    • 🚨 Did you know that the 2023 ESC Guidelines for the Management of Acute Coronary Syndromes will be released August 28th?!? ➡️ Get up to speed with our ACS activities ahead of #ESC2023 here: https://t.co/QmLhFCu9z0 #ACS #CardioX #ESCCongress #MedEd https://t.co/rGCCf5puJL